PAMMOLLI, FABIO
 Distribuzione geografica
Continente #
EU - Europa 3.007
NA - Nord America 1.534
AS - Asia 172
AF - Africa 16
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.731
Nazione #
PL - Polonia 2.136
US - Stati Uniti d'America 1.532
UA - Ucraina 195
SE - Svezia 150
IT - Italia 141
HK - Hong Kong 135
IE - Irlanda 133
DE - Germania 118
FI - Finlandia 48
VN - Vietnam 33
CH - Svizzera 32
GB - Regno Unito 27
SC - Seychelles 16
FR - Francia 13
RU - Federazione Russa 7
NL - Olanda 5
CN - Cina 3
CA - Canada 2
ES - Italia 2
EU - Europa 1
IR - Iran 1
NZ - Nuova Zelanda 1
Totale 4.731
Città #
Warsaw 2.136
Jacksonville 282
Fairfield 192
Chandler 167
Dublin 133
Hong Kong 94
Cambridge 83
Seattle 83
Wilmington 77
Ashburn 75
Houston 66
Woodbridge 64
Princeton 46
Boston 35
Bern 32
Dong Ket 27
Ann Arbor 23
Medford 19
San Diego 19
Florence 17
Boardman 14
Milan 13
Auburn Hills 12
Frankfurt Am Main 12
West Jordan 12
Verona 10
Los Angeles 8
Norwalk 8
Phoenix 8
Rome 6
Andover 5
Saint Louis 5
Hillsboro 4
Saint Petersburg 4
Noisy-le-sec 3
San Giorgio A Cremano 3
Serra 3
Bergamo 2
Bexleyheath 2
Capaccio 2
Catania 2
Crotone 2
Giulianova 2
Helsinki 2
Karlsruhe 2
Pregnana Milanese 2
Segrate 2
Valencia 2
Arezzo 1
Auckland 1
Aversa 1
Beijing 1
Bologna 1
Brescia 1
Central 1
Guido 1
Jönköping 1
Langfang 1
Laurel 1
Ludwigshafen 1
Ottawa 1
San Mateo 1
Santa Maria Imbaro 1
Toronto 1
Trebaseleghe 1
Turin 1
Totale 3.840
Nome #
A Comparison of U.S. and European University-Industry Relations in the Life Sciences 228
Il settore farmaceutico tra barriere alla concorrenza e regolazione sul lato del consumo 215
Statistical Properties of Business Firms Structure and Growth 213
Patent Disclosure and R&D Competition in Pharmaceuticals 213
Market Structure and Drug Innovation 211
Preferential Attachment and Growth Dynamics in Complex Systems 211
The Nature and Extent of the Market for Technology in Biopharmaceuticals 210
Economic Evaluation of HIV Treatments: The I.CO.N.A. Cohort Study 209
Introduzione. Liberalizzazioni e concorrenza in Italia 198
Intellectual Property, Technological Regimes and Market Dynamics 185
A Breath of Fresh Air? Firm Types, Scale, Scope and Selection Effects in Drug Development 183
Betweennes Centrality of Fractal and Non Fractal Scale Free Model Networks and Tests on Real Networks 182
A Generalized Preferential Attachment Model for Business Firms Growth Rates:I. Empirical Evidence 179
The Growth of Business Firms: Facts and Theory 178
Health Services in an Open Transatlantic Market: A European Perspective 177
Spesa sanitaria, demografia, istituzioni 165
Growth and Diversification Patterns of the Worldwide Pharmaceutical Industry 80
Innovation and Corporate Growth in the Evolution of the Drug Industry 79
The Growth of Business Firms: Theoretical Framework and Empirical Evidence 78
Public Research and Industrial Innovation: A comparison of U.S. and European Innovation Systems in the Life Sciences 72
The Intensity of Competition after Patent Expiry in Pharmaceuticals: a Cross-country Analysis 72
On the Size Distribution of Business Firms 70
On Size and Growth of Business Firms 70
Technological Competencies in Networks of Innovators 68
The size variance relationship of business firm growth rates 68
Technological Regimes and the Growth of Networks: An Empirical Analysis 62
Modelli e Strategie di Marketing 55
Innovation and Industrial Leadership: Lessons from Pharmaceuticals 53
Politiche di liberalizzazione e concorrenza in Italia 51
La distribuzione al dettaglio dei farmaci: tra regolazione efficiente e mercato 49
Technological Regimes and the Evolution of Networks. Lessons form Biotechnology and Pharmaceuticals 48
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment 48
I livelli essenziali di assistenza, la regolazione e la riforma multipilastro 45
Sicurezza, innovazione, crescita. Gli investimenti in difesa e il loro effetto sullo sviluppo economico e tecnologico 45
Europe and the United States : The Power of Networks. Lessons from Technology Transfer 44
Public Health, Innovation and Intellectual Property Rights 43
Dynamic Competition in Pharmaceuticals: on patent expiry, generic penetration and industry structure 43
Il sistema pensionistico: quale riforma? 41
Sicurezza, Innovazione, Crescita 40
On Firm Growth in Networks 39
Nuove Imprese, Concorrenza e Produttività 38
Size dependent standard deviation for growth rates: Empirical results and theoretical modelling 37
Regolazione di prezzo, innovazione e ciclo di vita dei prodotti: per una riforma del sistema di pricing nel settore farmaceutico 37
Technological Change and Network Dynamics: Lessons from the Pharmaceutical Industry 36
Il sistema di istruzione italiano: un confronto internazionale 35
Pharmaceuticals Analysed through the Lens of a Sectoral Innovation System 33
Totale 4.736
Categoria #
all - tutte 8.681
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.681


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019230 0 0 0 0 0 0 0 0 0 0 129 101
2019/20201.071 82 169 39 104 105 111 74 142 68 49 118 10
2020/2021853 63 76 62 106 32 114 37 85 56 128 10 84
2021/2022234 8 35 0 14 9 9 7 10 10 20 52 60
2022/2023637 76 18 16 43 63 142 69 57 74 11 29 39
2023/2024231 14 34 47 8 7 6 3 96 0 13 3 0
Totale 4.736